Cariprazine (Vraylar®)

Cariprazine (Vraylar®) is a second-generation (atypical) antipsychotic. Here is basic information about this medication.

FDA-approved indications

1. Schizophrenia
2. Acute treatment of manic or mixed episodes associated with bipolar I disorder.

Dosage

Schizophrenia

Starting: 1.5 mg/day
Recommended: 1.5–6 mg/day

Bipolar Mania

Starting: 1.5 mg/day
Recommended: 3–6 mg/day

Please refer to Prescribing Information (see link below) for complete discussion of dosage, administration, warnings and precautions, contraindications, etc.

Dosage forms and strengths

Capsules: 1.5 mg, 3 mg, 4.5 mg, and 6 mg


Published by Dr.Adel Serag

Dr. Adel Serag is a senior consultant psychiatrist , working clinical psychiatry over 30 years.